Sprycel (dasatinib tablets - Bristol-Myers Squibb; generic) — Cigna
Myeloid/Lymphoid Neoplasms with Eosinophilia
Initial criteria
- Approve for 1 year if BOTH of the following (A and B) are met:
- A) Patient age ≥ 18 years; AND
- B) The tumor has an ABL1 rearrangement.
Approval duration
1 year